 | • レポートコード：MRC2-11QY04280 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は形質細胞新生物治療のグローバル市場について調査・分析したレポートです。種類別（放射線療法、化学療法、生物学的製剤/標的療法）市場規模、用途別（病院、専門クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別形質細胞新生物治療の競争状況、市場シェア ・世界の形質細胞新生物治療市場：種類別市場規模 2015年-2020年（放射線療法、化学療法、生物学的製剤/標的療法） ・世界の形質細胞新生物治療市場：種類別市場規模予測 2021年-2026年（放射線療法、化学療法、生物学的製剤/標的療法） ・世界の形質細胞新生物治療市場：用途別市場規模 2015年-2020年（病院、専門クリニック、外来手術センター） ・世界の形質細胞新生物治療市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック、外来手術センター） ・北米の形質細胞新生物治療市場分析：米国、カナダ ・ヨーロッパの形質細胞新生物治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの形質細胞新生物治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の形質細胞新生物治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの形質細胞新生物治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Amgen、Bristol-Myers Squibb、Celgene、Janssen Biotech、Millennium Pharmaceutical、Novartis、Spectrum Pharmaceutical、Sun Pharmaceutical Industries ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Plasma cell neoplasms are diseases in which the body makes too many plasma cells.
The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken or can damage the kidneys.
Market Analysis and Insights: Global Plasma Cell Neoplasm Treatment Market
The global Plasma Cell Neoplasm Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Plasma Cell Neoplasm Treatment Scope and Market Size
Plasma Cell Neoplasm Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Cell Neoplasm Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie
Amgen
Bristol-Myers Squibb
Celgene
Janssen Biotech
Millennium Pharmaceutical
Novartis
Spectrum Pharmaceutical
Sun Pharmaceutical Industries
Market segment by Type, the product can be split into
Radiation Therapy
Chemotherapy
Biologics or Targeted Therapy
Market segment by Application, split into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Plasma Cell Neoplasm Treatment Revenue
1.4 Market by Type
1.4.1 Global Plasma Cell Neoplasm Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiation Therapy
1.4.3 Chemotherapy
1.4.4 Biologics or Targeted Therapy
1.5 Market by Application
1.5.1 Global Plasma Cell Neoplasm Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Plasma Cell Neoplasm Treatment Market Perspective (2015-2026)
2.2 Global Plasma Cell Neoplasm Treatment Growth Trends by Regions
2.2.1 Plasma Cell Neoplasm Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Plasma Cell Neoplasm Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Plasma Cell Neoplasm Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Plasma Cell Neoplasm Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Plasma Cell Neoplasm Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Plasma Cell Neoplasm Treatment Players by Market Size
3.1.1 Global Top Plasma Cell Neoplasm Treatment Players by Revenue (2015-2020)
3.1.2 Global Plasma Cell Neoplasm Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Plasma Cell Neoplasm Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Plasma Cell Neoplasm Treatment Market Concentration Ratio
3.2.1 Global Plasma Cell Neoplasm Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Plasma Cell Neoplasm Treatment Revenue in 2019
3.3 Plasma Cell Neoplasm Treatment Key Players Head office and Area Served
3.4 Key Players Plasma Cell Neoplasm Treatment Product Solution and Service
3.5 Date of Enter into Plasma Cell Neoplasm Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Plasma Cell Neoplasm Treatment Historic Market Size by Type (2015-2020)
4.2 Global Plasma Cell Neoplasm Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020)
5.2 Global Plasma Cell Neoplasm Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Plasma Cell Neoplasm Treatment Market Size (2015-2020)
6.2 Plasma Cell Neoplasm Treatment Key Players in North America (2019-2020)
6.3 North America Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020)
6.4 North America Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Plasma Cell Neoplasm Treatment Market Size (2015-2020)
7.2 Plasma Cell Neoplasm Treatment Key Players in Europe (2019-2020)
7.3 Europe Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020)
7.4 Europe Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020)
8 China
8.1 China Plasma Cell Neoplasm Treatment Market Size (2015-2020)
8.2 Plasma Cell Neoplasm Treatment Key Players in China (2019-2020)
8.3 China Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020)
8.4 China Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Plasma Cell Neoplasm Treatment Market Size (2015-2020)
9.2 Plasma Cell Neoplasm Treatment Key Players in Japan (2019-2020)
9.3 Japan Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020)
9.4 Japan Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Plasma Cell Neoplasm Treatment Market Size (2015-2020)
10.2 Plasma Cell Neoplasm Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020)
11 India
11.1 India Plasma Cell Neoplasm Treatment Market Size (2015-2020)
11.2 Plasma Cell Neoplasm Treatment Key Players in India (2019-2020)
11.3 India Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020)
11.4 India Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Plasma Cell Neoplasm Treatment Market Size (2015-2020)
12.2 Plasma Cell Neoplasm Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020)
12.4 Central & South America Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Plasma Cell Neoplasm Treatment Introduction
13.1.4 AbbVie Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Plasma Cell Neoplasm Treatment Introduction
13.2.4 Amgen Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb Plasma Cell Neoplasm Treatment Introduction
13.3.4 Bristol-Myers Squibb Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Celgene
13.4.1 Celgene Company Details
13.4.2 Celgene Business Overview
13.4.3 Celgene Plasma Cell Neoplasm Treatment Introduction
13.4.4 Celgene Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020)
13.4.5 Celgene Recent Development
13.5 Janssen Biotech
13.5.1 Janssen Biotech Company Details
13.5.2 Janssen Biotech Business Overview
13.5.3 Janssen Biotech Plasma Cell Neoplasm Treatment Introduction
13.5.4 Janssen Biotech Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020)
13.5.5 Janssen Biotech Recent Development
13.6 Millennium Pharmaceutical
13.6.1 Millennium Pharmaceutical Company Details
13.6.2 Millennium Pharmaceutical Business Overview
13.6.3 Millennium Pharmaceutical Plasma Cell Neoplasm Treatment Introduction
13.6.4 Millennium Pharmaceutical Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020)
13.6.5 Millennium Pharmaceutical Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Plasma Cell Neoplasm Treatment Introduction
13.7.4 Novartis Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Spectrum Pharmaceutical
13.8.1 Spectrum Pharmaceutical Company Details
13.8.2 Spectrum Pharmaceutical Business Overview
13.8.3 Spectrum Pharmaceutical Plasma Cell Neoplasm Treatment Introduction
13.8.4 Spectrum Pharmaceutical Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020)
13.8.5 Spectrum Pharmaceutical Recent Development
13.9 Sun Pharmaceutical Industries
13.9.1 Sun Pharmaceutical Industries Company Details
13.9.2 Sun Pharmaceutical Industries Business Overview
13.9.3 Sun Pharmaceutical Industries Plasma Cell Neoplasm Treatment Introduction
13.9.4 Sun Pharmaceutical Industries Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020)
13.9.5 Sun Pharmaceutical Industries Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Plasma Cell Neoplasm Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Plasma Cell Neoplasm Treatment Revenue
Table 3. Ranking of Global Top Plasma Cell Neoplasm Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Plasma Cell Neoplasm Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiation Therapy
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Biologics or Targeted Therapy
Table 8. Global Plasma Cell Neoplasm Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Plasma Cell Neoplasm Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Plasma Cell Neoplasm Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Plasma Cell Neoplasm Treatment Market Share by Regions (2015-2020)
Table 12. Global Plasma Cell Neoplasm Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Plasma Cell Neoplasm Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Plasma Cell Neoplasm Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Plasma Cell Neoplasm Treatment Players
Table 19. Global Plasma Cell Neoplasm Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Plasma Cell Neoplasm Treatment Market Share by Players (2015-2020)
Table 21. Global Top Plasma Cell Neoplasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Cell Neoplasm Treatment as of 2019)
Table 22. Global Plasma Cell Neoplasm Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Plasma Cell Neoplasm Treatment Product Solution and Service
Table 25. Date of Enter into Plasma Cell Neoplasm Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Plasma Cell Neoplasm Treatment Market Size Share by Type (2015-2020)
Table 29. Global Plasma Cell Neoplasm Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Plasma Cell Neoplasm Treatment Market Size Share by Application (2015-2020)
Table 31. Global Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Plasma Cell Neoplasm Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Plasma Cell Neoplasm Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Plasma Cell Neoplasm Treatment Market Share (2019-2020)
Table 35. North America Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Plasma Cell Neoplasm Treatment Market Share by Type (2015-2020)
Table 37. North America Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Plasma Cell Neoplasm Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Plasma Cell Neoplasm Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Plasma Cell Neoplasm Treatment Market Share (2019-2020)
Table 41. Europe Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Plasma Cell Neoplasm Treatment Market Share by Type (2015-2020)
Table 43. Europe Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Plasma Cell Neoplasm Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Plasma Cell Neoplasm Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Plasma Cell Neoplasm Treatment Market Share (2019-2020)
Table 47. China Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Plasma Cell Neoplasm Treatment Market Share by Type (2015-2020)
Table 49. China Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Plasma Cell Neoplasm Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Plasma Cell Neoplasm Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Plasma Cell Neoplasm Treatment Market Share (2019-2020)
Table 53. Japan Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Plasma Cell Neoplasm Treatment Market Share by Type (2015-2020)
Table 55. Japan Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Plasma Cell Neoplasm Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Plasma Cell Neoplasm Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Plasma Cell Neoplasm Treatment Market Share (2019-2020)
Table 59. Southeast Asia Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Plasma Cell Neoplasm Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Plasma Cell Neoplasm Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Plasma Cell Neoplasm Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Plasma Cell Neoplasm Treatment Market Share (2019-2020)
Table 65. India Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Plasma Cell Neoplasm Treatment Market Share by Type (2015-2020)
Table 67. India Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Plasma Cell Neoplasm Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Plasma Cell Neoplasm Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Plasma Cell Neoplasm Treatment Market Share (2019-2020)
Table 71. Central & South America Plasma Cell Neoplasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Plasma Cell Neoplasm Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Plasma Cell Neoplasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Plasma Cell Neoplasm Treatment Market Share by Application (2015-2020)
Table 75. AbbVie Company Details
Table 76. AbbVie Business Overview
Table 77. AbbVie Product
Table 78. AbbVie Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020) (Million US$)
Table 79. AbbVie Recent Development
Table 80. Amgen Company Details
Table 81. Amgen Business Overview
Table 82. Amgen Product
Table 83. Amgen Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020) (Million US$)
Table 84. Amgen Recent Development
Table 85. Bristol-Myers Squibb Company Details
Table 86. Bristol-Myers Squibb Business Overview
Table 87. Bristol-Myers Squibb Product
Table 88. Bristol-Myers Squibb Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020) (Million US$)
Table 89. Bristol-Myers Squibb Recent Development
Table 90. Celgene Company Details
Table 91. Celgene Business Overview
Table 92. Celgene Product
Table 93. Celgene Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020) (Million US$)
Table 94. Celgene Recent Development
Table 95. Janssen Biotech Company Details
Table 96. Janssen Biotech Business Overview
Table 97. Janssen Biotech Product
Table 98. Janssen Biotech Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020) (Million US$)
Table 99. Janssen Biotech Recent Development
Table 100. Millennium Pharmaceutical Company Details
Table 101. Millennium Pharmaceutical Business Overview
Table 102. Millennium Pharmaceutical Product
Table 103. Millennium Pharmaceutical Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020) (Million US$)
Table 104. Millennium Pharmaceutical Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Product
Table 108. Novartis Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020) (Million US$)
Table 109. Novartis Recent Development
Table 110. Spectrum Pharmaceutical Business Overview
Table 111. Spectrum Pharmaceutical Product
Table 112. Spectrum Pharmaceutical Company Details
Table 113. Spectrum Pharmaceutical Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020) (Million US$)
Table 114. Spectrum Pharmaceutical Recent Development
Table 115. Sun Pharmaceutical Industries Company Details
Table 116. Sun Pharmaceutical Industries Business Overview
Table 117. Sun Pharmaceutical Industries Product
Table 118. Sun Pharmaceutical Industries Revenue in Plasma Cell Neoplasm Treatment Business (2015-2020) (Million US$)
Table 119. Sun Pharmaceutical Industries Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Cell Neoplasm Treatment Market Share by Type: 2020 VS 2026
Figure 2. Radiation Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Biologics or Targeted Therapy Features
Figure 5. Global Plasma Cell Neoplasm Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Plasma Cell Neoplasm Treatment Report Years Considered
Figure 10. Global Plasma Cell Neoplasm Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Plasma Cell Neoplasm Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Plasma Cell Neoplasm Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Plasma Cell Neoplasm Treatment Market Share by Players in 2019
Figure 15. Global Top Plasma Cell Neoplasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Cell Neoplasm Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Plasma Cell Neoplasm Treatment Revenue in 2019
Figure 17. North America Plasma Cell Neoplasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Plasma Cell Neoplasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Plasma Cell Neoplasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Plasma Cell Neoplasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Plasma Cell Neoplasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Plasma Cell Neoplasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Plasma Cell Neoplasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…- 小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…
- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- 犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 巨細胞性動脈炎治療の世界市場（～2026年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …